← 返回专利悬崖列表



罗米地辛
Tier C · 观察 / 贸易Romidepsin
新基公司
原研
2009
首批上市
-
到期年(公开口径)
$0.08B ▲
峰值销售
化学药
类型
靶点:HDAC
商品名:Istodax
适应症(已批准):外周T细胞淋巴瘤、淋巴瘤
各地区研发/上市状态
美国
批准上市
2009-11-05
欧盟
终止
中国
-
日本
批准上市
2017-07-03
合成路线与中间体5 routes
原研路线 × 1优化路线(非专利)× 4工艺路线 × 0
路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。
优化Route 2步骤 12 · 总收率 /

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| ROMI-013 | 88158-68-3 | (but-3-yn-1-yloxy)(tert-butyl)diphenylsilane |
| ROMI-014 | 1009301-11-4 | 7-((tert-butyldiphenylsilyl)oxy)-1,1-dimethoxyhept-4-yn-3-one |
| ROMI-015 | - | - |
| ROMI-016 | 1009301-13-6 | (R,E)-7-((tert-butyldiphenylsilyl)oxy)-1,1-dimethoxyhept-4-en-3-ol |
| ROMI-017 | 1009301-15-8 | (R,E)-5-hydroxy-7,7-dimethoxyhept-3-en-1-yl 4-methylbenzenesulfonate |
| ROMI-003 | 180973-42-6 | methyl (((9H-fluoren-9-yl)methoxy)carbonyl)-L-threonyl-L-valinate |
| ROMI-004 | 1009301-28-3 | methyl N-((allyloxy)carbonyl)-S-trityl-D-cysteinyl-L-threonyl-L-valinate |
| ROMI-005 | 1009301-19-2 | methyl ((Z)-2-((S)-2-(((allyloxy)carbonyl)amino)-3-(tritylthio)propanamido)but-2-enoyl)-L-valinate |
| ROMI-006 | 1009301-21-6 | methyl ((Z)-2-((S)-2-((R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanamido)-3-(tritylthio)propanamido)but-2-enoyl)-L-valinate |
| ROMI-007 | 180973-32-4 | methyl ((Z)-2-((S)-2-((R)-2-amino-3-methylbutanamido)-3-(tritylthio)propanamido)but-2-enoyl)-L-valinate |
| ROMI-008 | 180973-26-6 | (R,E)-3-hydroxy-7-(tritylthio)hept-4-enoic acid |
| ROMI-009 | 181141-24-2 | methyl ((Z)-2-((S)-2-((R)-2-((R,E)-3-hydroxy-7-(tritylthio)hept-4-enamido)-3-methylbutanamido)-3-(tritylthio)propanamido)but-2-enoyl)-L-valinate |
| ROMI-010 | - | (3S,9S,12R,16S,Z)-6-ethylidene-3,12-diisopropyl-16-((E)-4-(tritylthio)but-1-en-1-yl)-9-((tritylthio)methyl)-1-oxa-4,7,10,13-tetraazacyclohexadecane-2,5,8,11,14-pentaone |
| ROMI-011 | 7424-91-1 | methyl 3,3-dimethoxypropanoate |
| ROMI-012 | 1009301-09-0 | N,3,3-trimethoxy-N-methylpropanamide |
优化Route 3步骤 11 · 总收率 /

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| ROMI-007 | 180973-32-4 | methyl ((Z)-2-((S)-2-((R)-2-amino-3-methylbutanamido)-3-(tritylthio)propanamido)but-2-enoyl)-L-valinate |
| ROMI-008 | 180973-26-6 | (R,E)-3-hydroxy-7-(tritylthio)hept-4-enoic acid |
| ROMI-009 | 181141-24-2 | methyl ((Z)-2-((S)-2-((R)-2-((R,E)-3-hydroxy-7-(tritylthio)hept-4-enamido)-3-methylbutanamido)-3-(tritylthio)propanamido)but-2-enoyl)-L-valinate |
| ROMI-018 | 4070-48-8 | (S)-methyl 2-amino-3-methylbutanoate |
| ROMI-019 | 180973-28-8 | methyl N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-trityl-D-cysteinyl-L-threonyl-L-valinate |
| ROMI-020 | 180973-30-2 | methyl N-((((9H-fluoren-9-yl)methoxy)carbonyl)-D-valyl)-S-trityl-D-cysteinyl-L-threonyl-L-valinate |
| ROMI-021 | 180973-31-3 | methyl N-(N-((((9H-fluoren-9-yl)methoxy)carbonyl)-D-valyl)-S-trityl-D-cysteinyl)-O-tosyl-L-threonyl-L-valinate |
| ROMI-022 | 181141-25-3 | ((Z)-2-((S)-2-((R)-2-((R,E)-3-hydroxy-7-(tritylthio)hept-4-enamido)-3-methylbutanamido)-3-(tritylthio)propanamido)but-2-enoyl)-L-valine |
| ROMI-023 | - | (3S,9S,12R,16S,Z)-6-ethylidene-3,12-diisopropyl-16-((E)-4-(tritylthio)but-1-en-1-yl)-9-((tritylthio)methyl)-1-oxa-4,7,10,13-tetraazacyclohexadecane-2,5,8,11,14-pentaone |
| ROMI-024 | 1515-75-9 | methyl (E)-penta-2,4-dienoate |
| ROMI-025 | 180973-22-2 | (E)-5-(tritylthio)pent-2-enal |
| ROMI-026 | 81171-44-0 | ((1-(benzyloxy)vinyl)oxy)trimethylsilane |
| ROMI-027 | 180973-41-5 | benzyl (R,E)-3-hydroxy-7-(tritylthio)hept-4-enoate |
优化Route 4步骤 8 · 总收率 53.6 mg

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| ROMI-008 | 180973-26-6 | (R,E)-3-hydroxy-7-(tritylthio)hept-4-enoic acid |
| ROMI-028 | 1089192-59-5 | - |
| ROMI-029 | 1089192-60-8 | - |
| ROMI-030 | 1089192-61-9 | - |
| ROMI-031 | 1089192-62-0 | - |
| ROMI-032 | 1089192-63-1 | - |
| ROMI-033 | 1089192-64-2 | ((Z)-2-((S)-2-((R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanamido)-3-(tritylthio)propanamido)but-2-enoyl)-L-valine |
| ROMI-034 | 1043577-31-6 | - |
| ROMI-035 | 1089192-65-3 | - |
| ROMI-036 | 663918-95-4 | (S,E)-3-hydroxy-1-((R)-4-isopropyl-2-thioxothiazolidin-3-yl)-7-(tritylthio)hept-4-en-1-one |
优化Route 5步骤 8 · 总收率 30 mg

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| ROMI-019 | 180973-28-8 | methyl N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-trityl-D-cysteinyl-L-threonyl-L-valinate |
| ROMI-023 | - | (3S,9S,12R,16S,Z)-6-ethylidene-3,12-diisopropyl-16-((E)-4-(tritylthio)but-1-en-1-yl)-9-((tritylthio)methyl)-1-oxa-4,7,10,13-tetraazacyclohexadecane-2,5,8,11,14-pentaone |
| ROMI-034 | 1043577-31-6 | - |
| ROMI-037 | 167015-11-4 | N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-trityl-D-cysteine |
| ROMI-038 | 1089192-67-5 | methyl N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-trityl-D-cysteinyl-L-threoninate |
| ROMI-039 | 1089192-69-7 | methyl (Z)-2-((S)-2-((R)-2-amino-3-methylbutanamido)-3-(tritylthio)propanamido)but-2-enoate |
| ROMI-040 | 1089192-70-0 | (5R,8S,Z)-11-ethylidene-1-(9H-fluoren-9-yl)-5-isopropyl-3,6,9-trioxo-8-((tritylthio)methyl)-2-oxa-4,7,10-triazadodecan-12-oic acid |
| ROMI-041 | - | - |
| ROMI-042 | 1089192-65-3 | - |
| ROMI-043 | 68858-20-8 | (((9H-fluoren-9-yl)methoxy)carbonyl)-L-valine |
常见问题(FAQ)
罗米地辛的适应症有哪些?
已批准的适应症包括:外周T细胞淋巴瘤、淋巴瘤。
罗米地辛的专利什么时候到期?
罗米地辛的专利到期年暂无公开口径,本页会在数据管道核实后更新。
罗米地辛有几条合成路线?
本站收录 5 条合成路线,最短路线 1 步、总收率 /。每条路线的中间体均带登记编号与 CAS 号。
罗米地辛的关键中间体在哪里可以采购?
罗米地辛路线中的中间体均已建立 CAS 档案,可直接按 CAS 发起询价,需求会进入供应网络撮合池。
如何获取罗米地辛中间体的报价?
在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。
数据来源:多源数据交叉核实(仅结构化字段) · 2026-09-24
